How many studies have been conducted on Epiregulin?

BiohacksAI has indexed 299 PubMed studies on Epiregulin, including 3 randomized controlled trials (RCTs). 31% of studies involve human subjects.

What are the main research areas for Epiregulin?

The primary research domains for Epiregulin are 🔬 Oncology, 🫘 Kidney, ✨ Skin & Hair. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Epiregulin

A member of the epidermal growth factor (EGF) family of peptide growth factors that is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. Epiregulin has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR.

299+ PubMed studies analyzed · 3 RCTs · Evidence Score: 48.2

Research Domains

Epiregulin has been studied across 22 research domains including 🔬 Oncology, 🫘 Kidney, ✨ Skin & Hair, 🔬 Inflammation, 🧬 Hormones. The primary research focus is 🔬 Oncology with 43% of studies addressing this area.

Loading evidence profile...

This evidence profile for Epiregulin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.